Connect with us


COVID-19 Vaccines May Not Come Soon –Nigeria’s Fed Govt

The government stated that the long-awaited vaccines against the virus might not be arriving as soon as the people may have been expecting.



The Federal Government of Nigeria has warned Nigerian citizens against being complacent and letting their guard down in containing the COVID-19 pandemic.

The government stated that the long-awaited vaccines against the virus might not be arriving as soon as the people may have been expecting.

The country’s Minister of State for Health, Olorunnimbe Mamora, made this statement on Thursday in Abuja the nation’s capital, at the Presidential Task Force on COVID-19 briefing.

Mamora did however assured Nigerians that regardless of the delay, the government was working very hard to acquire vaccines.

The Minister of State for Health was represented by the Director, Hospital Services, Federal Ministry of Health, Dr. Adebimpe Adebiyi.

“We need to be alive to get the vaccines when they come. I have brought this up to underscore the importance of compliance with non-pharmaceutical measures as advised to reduce transmission.

“The Federal Government is determined to ensure morbidity due to COVID-19 is reduced to the barest minimum while improving on the fatality rate,” he said.

Dr. Adebiyi added that appropriate measures were being taken by the Federal government to achieve the objectives.

Like many other African countries, Nigeria is currently experiencing a second wave of the COVID-19 pandemic as the number of recorded cases have been steadily rising, with Lagos State, the country’s commercial nerve center, constantly recording the largest figures.

On January 3, The Lagos State Government announced that all public and private schools below tertiary school level in the State are to remain closed indefinitely due to the outbreak of the second wave of the coronavirus pandemic.

The total number of recoded COVID-19 cases in the country is now more than 94,000 with over 1,300 reported COVID-19 related deaths.

Join our newsletter

Continue Reading
Click to comment

Leave a Reply


South Africa’s Mining Industry to Support COVID-19 Vaccine Rollout

The mining companies say they are well-positioned to support the COVID-19 response due to decades of experience combatting tuberculosis and HIV-AIDS among workers, including the creation of on-site treatment facilities.



In a bid to help curb the spread of coronavirus infection rates, South Africa’s mining companies, otherwise known as the Minerals Council have announced that they will support the government in the rollout of COVID-19 vaccines as the country battles a spike in infections.

The mining companies say they are well-positioned to support the COVID-19 response due to decades of experience combatting tuberculosis and HIV-AIDS among workers, including the creation of on-site treatment facilities.
Also, The Minerals Council said its members are developing plans to use the sector’s healthcare infrastructure and delivery capability to accelerate the vaccination programme.

The government has called on the private sector, including miners, to assist with the rollout of vaccines but has not yet outlined exactly how it should assist.

According to the Minerals Council CEO Roger Baxter, he said: “While Government is primarily responsible for funding the vaccine rollout and is the single buyer, the industry can play a material role in accelerating the vaccination programme on mines and in mining communities.”

Keep Reading:

COVID-19: South Africa Shuts Land Borders

South Africa’s Biggest Pharmacies To Offer COVID-19 Vaccines

COVID-19: South Africa to Receive 1.5 Million Doses of AstraZeneca Vaccine from India

 Medical Schemes To Partly Fund South Africa’s COVID-19 Vaccination

Precious metals producer Sibanye-Stillwater disclosed that it could carry out 18,000 vaccinations a day using its 45 health and medical facilities. “We could probably vaccinate our entire workforce of around 80,000 people in about a week,” said Sibanye spokesman James Wellsted, while adding that talks were ongoing about extending vaccinations to the community.

Earlier this week, President Cyril Ramaphosa said 20 million doses of COVID-19 vaccines have been secured as the country battles infections which reached a peak of more than 21,000 a day, taking total cases to nearly 1.3 million, which is the most on the African continent.

With over 230 COVID-19 deaths in the mining industry, unions have called on mining firms to help pay for vaccines. “They have been making huge profits, and now it’s time for them to buy vaccines for their employees,” said National Union of Mineworkers (NUM) spokesman Livhuwani Mammburu.

In a revealing budget for the vaccines, South Africa’s government has said it might meet 70% of its vaccine needs with AstraZeneca’s shot, which is the cheapest at an estimated 54 Rand ($3.56) per dose. At that price, vaccinating all the country’s more than 470,000 mineworkers with the two-dose regimen from AstraZeneca will cost around 50.9 million rands ($3.36 million).

Join our newsletter

Continue Reading


COVID-19: We Haven’t Approved Any Vaccine Yet — NAFDAC DG

The NAFDAC boss reiterated readiness of the agency to examine the safety of any vaccine before being approved for Nigerians.



The Director-General, National Agency for Food and Drug Administration and Control (NAFDAC), says the agency has not approved any COVID-19 vaccines for Nigeria just yet.

NAFDAC’s DG Mojisola Adeyeye, made this known in a statement issued on Friday in Nigeria’s capital Abuja.

She stated that no application from vaccine manufacturers had been received by the agency “and therefore, no vaccine had been approved by NAFDAC.

“There are reports of fake vaccines in Nigeria; NAFDAC is pleading with the public to beware. COVID-19 vaccines are new, and the side effects must be monitored.

“No COVID-19 vaccine has been approved by NAFDAC. Fake vaccines can cause COVID-like illnesses or other serious diseases that can kill.’’

While reiterating the commitment of the agency toward guaranteeing drugs security, the DG warned companies and corporate bodies against the unapproved ordering of any vaccine, noting that genuine manufacturing companies had to first submit applications to NAFDAC.

“No government establishment or agencies should order for COVID-19 vaccines without confirming from NAFDAC.

“However, NAFDAC is discussing with manufacturers of candidate COVID-19 vaccines concerning potential Emergency Use Authorization (EUA),
registration or licencing of their products as the case may be.”

Adeyeye however assured applicants of NAFDAC’s determination to approve vaccines for emergency use if phase three clinical data were convincing and robust with regards to safety and efficacy, and the vaccine had been submitted for the World Health Organisation (WHO) emergency use listing.

She laid emphasis on the commitment of the agency in using “Reliance” or “Recognition” to expedite Emergency Use Authorization (EUA) for vaccines that already have been approved by mature regulatory authorities.

“The full dossiers submitted by the manufacturer or Market Authorisation Holder (MAH) will be thoroughly reviewed by the Vaccine Committee that is made up of multiple directorates in the agency.”

The NAFDAC boss reiterated readiness of the agency to examine the safety of any vaccine before being approved for Nigerians.

She affirmed NAFDAC’s collaboration with sister agencies as the National Primary Health Care Development Agency (NPHCDA), Nigeria Centre for Disease Control (NCDC), UNICEF, WHO and the Ministry of Health, aimed at achieving a holistic approach for effective immunisation and delivery.

“NAFDAC plans to also use Traceability with GS1 Technology to monitor vaccine distribution, using Global Trade Item Number (GTIN).

“The goal is to prevent fake vaccines from infiltrating the supply chain and to ensure there is no diversion.

“This effort will create a reliable and predictable supply chain. The multi-stakeholder technical working group has been meeting to address different issues from
access to distribution to traceability to the monitoring of adverse events following immunisation.

“NAFDAC is also a member of Regulators Steering Committee of African Union -3S (Smart, Safety, Surveillance) with Ghana, South Africa and Ethiopia, collaborating
with UK Medicines Healthcare Products Regulatory Agency (MHRA) with funding from Bill and Melinda gates Foundation.”

Adeyeye concluded by explaining that the purpose of the continental collaboration was to use COVID-19 vaccines immunisation and distribution as a pilot to actively monitor the distribution, delivery and monitoring of Adverse Effects Following Immunisation at the continental level, targeted at creating an African-based vigilance system for the safety of medicines.

Join our newsletter

Continue Reading


COVID-19 Kills 13 in Nigeria’s Lagos



No fewer than 13 people died from the coronavirus (COVID-19) disease in Nigeria’s commercial nerve centre, Lagos State, on Monday 11 January 2021.

According to the Lagos State Commissioner for Health, Prof. Akin Abayomi, the number is Lagos highest daily fatalities since the inception of the pandemic.

Abayomi made the disclosure through his verified Twitter account @ProfAkinAbayomi on Friday while giving the state’s COVID-19 update for Jan. 11.

According to him, the new confirmed deaths increased the number of COVID-19 fatalities in the state to 262.

He said that 435 new COVID-19 infections were confirmed in the state on the date, increasing the state’s total number of COVID-19 infections to 37,284.

Abayomi added that the total number of COVID-19 tests conducted in the state since inception of the pandemic stood at 246,534.

According to him, 3,139 COVID-19 patients, who have been successfully treated and recovered, were discharged from the state’s care centres.

“Total number of #COVID19 recovery in communities – 25, 767.

“Cases currently under isolation – 192, active cases under home based care are 7,924,” he said.

Data from the World Health Organisation Africa Region shows that there were over three million confirmed COVID-19 cases on the continent with more than 2.5 million recoveries and 74,000 deaths cumulatively.

Join our newsletter

Continue Reading